SCL Science Statistics

Total Valuation

SCL Science has a market cap or net worth of KRW 68.68 billion. The enterprise value is 71.90 billion.

Market Cap	68.68B
Enterprise Value	71.90B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

SCL Science has 8.48 million shares outstanding. The number of shares has increased by 15.64% in one year.

Current Share Class	8.48M
Shares Outstanding	8.48M
Shares Change (YoY)	+15.64%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	5.32%
Owned by Institutions (%)	n/a
Float	3.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.50
PB Ratio	4.40
P/TBV Ratio	5.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.28
EV / Sales	15.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-10.99

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.27.

Current Ratio	1.61
Quick Ratio	1.05
Debt / Equity	0.27
Debt / EBITDA	n/a
Debt / FCF	-0.65
Interest Coverage	-14.01

Financial Efficiency

Return on equity (ROE) is -21.63% and return on invested capital (ROIC) is -9.77%.

Return on Equity (ROE)	-21.63%
Return on Assets (ROA)	-8.44%
Return on Invested Capital (ROIC)	-9.77%
Return on Capital Employed (ROCE)	-17.71%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.17
Inventory Turnover	6.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.94% in the last 52 weeks. The beta is 0.45, so SCL Science's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-7.94%
50-Day Moving Average	8,130.80
200-Day Moving Average	8,741.55
Relative Strength Index (RSI)	48.52
Average Volume (20 Days)	3,798

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCL Science had revenue of KRW 4.74 billion and -3.73 billion in losses. Loss per share was -513.42.

Revenue	4.74B
Gross Profit	1.81B
Operating Income	-3.66B
Pretax Income	-3.73B
Net Income	-3.73B
EBITDA	-2.53B
EBIT	-3.66B
Loss Per Share	-513.42

Full Income Statement

Balance Sheet

The company has 1.11 billion in cash and 4.26 billion in debt, giving a net cash position of -3.15 billion or -370.94 per share.

Cash & Cash Equivalents	1.11B
Total Debt	4.26B
Net Cash	-3.15B
Net Cash Per Share	-370.94
Equity (Book Value)	15.59B
Book Value Per Share	2,130.51
Working Capital	2.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.96 billion and capital expenditures -586.41 million, giving a free cash flow of -6.55 billion.

Operating Cash Flow	-5.96B
Capital Expenditures	-586.41M
Free Cash Flow	-6.55B
FCF Per Share	-771.92

Full Cash Flow Statement

Margins

Gross margin is 38.18%, with operating and profit margins of -77.28% and -78.74%.

Gross Margin	38.18%
Operating Margin	-77.28%
Pretax Margin	-78.73%
Profit Margin	-78.74%
EBITDA Margin	-53.39%
EBIT Margin	-77.28%
FCF Margin	n/a

Dividends & Yields

SCL Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.64%
Shareholder Yield	-15.64%
Earnings Yield	-5.43%
FCF Yield	-9.53%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SCL Science has an Altman Z-Score of 2.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	n/a